MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qad.0b013e328314b5f1

Медицинская библиотека · AIDS (London, England) · 2008

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

Mussini Cristina, Manzardo Christian, Johnson Margaret, Monforte Antonella d'Arminio, Uberti-Foppa Caterina, Antinori Andrea, Gill M John, Sighinolfi Laura, Borghi Vanni, Lazzarin Adriano, Miró José M, Sabin Caroline, Late Presenter Investigators

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Many patients infected with HIV still present with an AIDS diagnosis. The aim of this study was to evaluate the virological, immunological and clinical outcomes of HAART in these patients.

DESIGN

The present study was a multi-cohort study. All patients with an AIDS diagnosis between 30 days before and 14 days after HIV diagnosis, recruited between 1997 and 2004 from eight hospital cohorts, were evaluated.

RESULTS

A total of 760 patients were included [268 (35.3%) had pneumocystis and 168 (22.1%) tuberculosis]. Six hundred and twenty-four patients (82.1%) started HAART a median of 31 days after HIV diagnosis. One hundred and fifty-three patients started a nonnucleoside transcriptase inhibitor-based regimen (20.1%), 409 a protease inhibitor-based regimen (53.8%) and 62 other regimens (8.2%). In adjusted analyses, HAART was started sooner in more recent years, in patients with lower CD4 cell count and in those with Kaposi's sarcoma, whereas it was started later in those with tuberculosis. Five hundred and five patients (89%) attained a viral load of less than 500 copies/ml. The factors associated with a better virological response were later calendar year, lower initial viral load and cytomegalovirus disease. Virological rebound was more common in those receiving nucleoside reverse transcriptase inhibitor-based regimens, in those with tuberculosis and in earlier calendar years. One hundred and twenty-five (16%) patients died; 61 had received HAART (48.6%). Mortality was more likely in those who were older, those with a higher viral load at diagnosis, those with nonsexual HIV risks and those with lower CD4 cell count and haemoglobin levels over follow-up.

CONCLUSION

Virological suppression was achieved in most AIDS patients, though mortality remains high in these individuals.

Для цитирования: Mussini Cristina, Manzardo Christian, Johnson Margaret, Monforte Antonella d'Arminio, Uberti-Foppa Caterina, Antinori Andrea, Gill M John, Sighinolfi Laura, Borghi Vanni, Lazzarin Adriano, Miró José M, Sabin Caroline, Late Presenter Investigators. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.. AIDS (London, England). 2008. DOI: 10.1097/qad.0b013e328314b5f1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.